Mild Lesch-Nyhan disease in a boy with a null-mutation in HPRT1: an exception to the known genotype-phenotype correlation: three-year follow up.

Main Article Content

Allan Bayat Annika Wollenberg Juul


Lesch-Nyhan disease and its attenuated variants are caused by deficiency of the purine salvage enzyme, hypoxanthine-guanine phosphoribosyltransferase (HPRT). HPRT deficiency results in a continuous spectrum of clinical phenotypes though all include overproduction of uric acid with nephrolithiasis, renal failure, gouty arthritis and tophi.HPRT1 mutations that result in very low or no HPRT enzyme activities are generally associated with the classic Lesch-Nyhan disease (LND) phenotype with intellectual disability, motor handicap and self-injurious behaviour. Mutations that permit a higher residual HPRT activity are seen in some patients with the milder LND variant phenotypes with varying degrees of cognitive, motor handicap and maladaptive behaviour without recurrent self-injury. We have previously presented a 10-year-old boy with a LND variant phenotype due to a deletion of exon 5 of HPRT1 predicted to fully abolish HPRT activity. Metabolic analysis confirmed lack of significant residual enzyme activity. He presented with hyperuricemia, hypotonia, developmental delay, extrapyramidal and pyramidal involvement. This boy is one of the rare cases with a suspected null-mutation in HPRT1, that associates with a milder than expected phenotype with lack of self-injurious behaviour. He is currently 13-years-old and has yet to show any signs of self-injurious or maladaptive behaviour. We furthermore present our experience with oral baclofen in this patient.

Article Details

How to Cite
BAYAT, Allan; JUUL, Annika Wollenberg. Mild Lesch-Nyhan disease in a boy with a null-mutation in HPRT1: an exception to the known genotype-phenotype correlation: three-year follow up.. Medical Research Archives, [S.l.], v. 4, n. 6, oct. 2016. ISSN 2375-1924. Available at: <>. Date accessed: 25 june 2024.
Lesch-Nyhan, Hypoxanthine-guanine phosphoribosyltransferase, HPRT1, genotype-phenotype correlation
Case Reports


Abel, T. J., Dalm, B. D., Grossbach, A. J., Jackson, A. W., Thomsen, T., & Greenlee, J. D. (2014). Lateralized effect of pallidal stimulation on self-mutilation in Lesch-Nyhan disease. J Neurosurg.Pediatr., 14, 594-597.

Bayat, A., Christensen, M., Wibrand, F., Duno, M., & Lund, A. (2015). Mild Lesch-Nyhan Disease in a Boy with a Null Mutation in HPRT1: An Exception to the Known Genotype-Phenotype Correlation. JIMD.Rep., 18, 135-137.

Deon, L. L., Kalichman, M. A., Booth, C. L., Slavin, K. V., & Gaebler-Spira, D. J. (2012). Pallidal deep-brain stimulation associated with complete remission of self-injurious behaviors in a patient with Lesch-Nyhan syndrome: a case report. J Child Neurol., 27, 117-120.

Fu, R., Ceballos-Picot, I., Torres, R. J., Larovere, L. E., Yamada, Y., Nguyen, K. V. et al. (2013). Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain.

Jinnah, H. A., Ceballos-Picot, I., Torres, R. J., Visser, J. E., Schretlen, D. J., Verdu, A. et al. (2010). Attenuated variants of Lesch-Nyhan disease. Brain, 133, 671-689.

Jinnah, H. A., Harris, J. C., Nyhan, W. L., & O'Neill, J. P. (2004). The spectrum of mutations causing HPRT deficiency: an update. Nucleosides Nucleotides Nucleic Acids, 23, 1153-1160.

Jinnah, H. A., Visser, J. E., Harris, J. C., Verdu, A., Larovere, L., Ceballos-Picot, I. et al. (2006). Delineation of the motor disorder of Lesch-Nyhan disease. Brain, 129, 1201-1217.

Mak, B. S., Chi, C. S., Tsai, C. R., Lee, W. J., & Lin, H. Y. (2000). New mutations of the HPRT gene in Lesch-Nyhan syndrome. Pediatr.Neurol., 23, 332-335.

McCarthy, G. T., Green, E. M., Ogunbona, O., Simmonds, H. A., Fairbanks, L., Pountney, T. et al. (2011). A population study of Lesch-Nyhan disease in the UK. Dev.Med Child Neurol., 53, 34-39.

Piedimonte, F., Andreani, J. C., Piedimonte, L., Micheli, F., Graff, P., & Bacaro, V. (2015). Remarkable clinical improvement with bilateral globus pallidus internus deep brain stimulation in a case of Lesch-Nyhan disease: five-year follow-up. Neuromodulation., 18, 118-122.

Pozzi, M., Piccinini, L., Gallo, M., Motta, F., Radice, S., & Clementi, E. (2014). Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen. Orphanet.J Rare.Dis, 9, 208.

Shin-Buehring, Y. S., Osang, M., Wirtz, A., Haas, B., Rahm, P., & Schaub, J. (1980). Prenatal diagnosis of Lesch-Nyhan syndrome and some characteristics of hypoxanthine-guanine phosphoribosyltransferase and adenine phosphoribosyltransferase in human tissues and cultivated cells. Pediatr.Res., 14, 825-829.

Torres, R. J., Garcia, M. G., & Puig, J. G. (2010). Partial HPRT deficiency phenotype and incomplete splicing mutation. Nucleosides Nucleotides Nucleic Acids, 29, 295-300.

Torres, R. J. & Puig, J. G. (2007). Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet.J.Rare.Dis., 2, 48.

Torres, R. J., Puig, J. G., & Jinnah, H. A. (2012). Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants. Curr.Rheumatol.Rep., 14, 189-194.